Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. Íssur hf.
  6. Summary
    OSSR   IS0000000040

ÍSSUR HF.

(OSSR)
  Report
Delayed Nasdaq Copenhagen  -  10:59 2022-12-09 am EST
32.20 DKK    0.00%
11/22Össur Hf : Notification of Managers and Closely Related Parties' Transactions
AQ
10/31Össur hf. completed the acquisition of Proreva, Orthopedisch Maatwerk.
CI
10/25Össur Suspends $10 Million Share Buyback Program
MT
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Copenhagen
12/05/2022 12/06/2022 12/07/2022 12/08/2022 12/09/2022 Date
33.2(c) 32(c) 32.4(c) 32.2(c) 32.2(c) Last
14 320 7 649 11 064 47 605 32 985 Volume
+1.68% -3.61% +1.25% -0.62% 0.00% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 720 M - -
Net income 2022 46,5 M - -
Net Debt 2022 286 M - -
P/E ratio 2022 36,0x
Yield 2022 0,12%
Sales 2023 778 M - -
Net income 2023 70,8 M - -
Net Debt 2023 236 M - -
P/E ratio 2023 24,3x
Yield 2023 0,13%
Capitalization 1 918 M 1 918 M -
EV / Sales 2022 3,06x
EV / Sales 2023 2,77x
Nbr of Employees 4 000
Free-Float 47,6%
More Financials
Company
Ossur hf is an Iceland-based company that operates within the field of medical equipment and supplies sector. The Company is active in the development and distribution of products in the fields of non-invasive prosthetics, medical braces and supports. The Company is divided into three market segments: Bracing and Supports, which offers products for therapeutic and preventive purposes; Prosthetics, which offers... 
More about the company
Ratings of Íssur hf.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about ÍSSUR HF.
11/22Össur Hf : Notification of Managers and Closely Related Parties' Transactions
AQ
10/31Össur hf. completed the acquisition of Proreva, Orthopedisch Maatwerk.
CI
10/25Össur Suspends $10 Million Share Buyback Program
MT
10/25Transcript : Össur hf., Q3 2022 Earnings Call, Oct 25, 2022
CI
10/25Össur Hf : Össur Temporarily Pauses Share Buybacks
AQ
10/25Össur Hf : Interim Report Q3 2022
AQ
10/25Össur hf. Provides Earnings Guidance for the Year 2022
CI
10/25Össur hf. Reports Earnings Results for the Third Quarter and Nine Months Ended Septembe..
CI
10/17Össur Hf : Transactions in Relation to Share Buyback Program
AQ
10/17Össur hf. commences an Equity Buyback Plan for 10% of its issued share capital, under t..
CI
10/11Össur Hf : Q3 2022 Results - Conference Call Tuesday 25 October at 9:00 CEST
AQ
10/07Össur to Repurchase Up to $10 Million Worth of Shares in New Buyback Program
MT
10/07Össur Hf : Össur Initiates a New Share Buyback Program
AQ
10/07Össur Hf : Share Buyback Program Completed
AQ
10/07Tranche Update on Össur hf.'s Equity Buyback Plan announced on February 11, 2022.
CI
More news
News in other languages on ÍSSUR HF.
10/31Össur hf. (CPSE:OSSR) a achevé l'acquisition de Proreva, Orthopedisch Ma..
10/25Össur suspend son programme de rachat d'actions de 10 millions de dollars
10/25Össur hf. fournit des prévisions de bénéfices pour l'année 2022
10/25Össur hf. annonce ses résultats pour le troisième trimestre et les neuf mois se termina..
10/17Össur hf. (CPSE:OSSR) lance un plan de rachat d'actions portant sur 10% ..
More news
Chart ÍSSUR HF.
Duration : Period :
Íssur hf. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ÍSSUR HF.
Short TermMid-TermLong Term
TrendsBearishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 32,20 DKK
Average target price 36,45 DKK
Spread / Average Target 13,2%
EPS Revisions
Managers and Directors
Sveinn S÷lvason President & Chief Executive Officer
Gudny Arna Sveinsdottir Chief Financial Officer
Niels Jacobsen Chairman
Kristleifur Kristjansson Executive Vice President-Research & Development
Gudjon G. Karason Executive Vice President-Clinics
Sector and Competitors
1st jan.Capi. (M$)
ÖSSUR HF.-23.88%1 918
STRAUMANN HOLDING AG-44.84%18 208
SONOVA HOLDING AG-32.36%15 553
COCHLEAR LIMITED-3.50%9 273
DEMANT A/S-42.55%6 015
EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.3.15%3 222